Home > Healthcare > Medical Devices > Therapeutic Devices > Drug-eluting Balloon Catheters Market

Drug-eluting Balloon Catheters Market Size

Report ID: GMI5243
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Drug-eluting Balloon Catheters Market Size

Drug-Eluting Balloon Catheters Market size was valued at around USD 582 million in 2022 and is estimated to witness 11.5% CAGR between 2023 and 2032. The high industry expansion can be primarily attributed to factors including advancements in drug delivery technologies, growing trend towards minimally invasive procedures, rising awareness and increasing incidence of cardiovascular diseases among others.

To get key market trends

Download Free Sample

According to the World Health Organization (WHO), cardiovascular diseases are a leading cause of mortality globally, accounting for a significant percentage of deaths. For instance, as per the 2023 report by Centers for Disease Control and Prevention (CDC), there were around 0.7 million deaths from heart related diseases in the U.S.

Moreover, ongoing advancements in drug delivery technologies contribute to the development of more effective and targeted drug-eluting balloon catheters. Drug-eluting balloon catheters, with their anti-proliferative drug coatings, aim to reduce the incidence of restenosis compared to traditional angioplasty. Furthermore, increasing awareness among healthcare professionals and patients about the benefits of drug-eluting balloon catheters contributes to higher adoption rates.

Drug eluting balloon catheters or drug coated balloons aide in treating hyperplasia. The catheter carries an antiproliferative drug, usually paclitaxel or sirolimus that is delivered to the arterial walls as the balloon expands. Additionally, it offers controlled drug delivery to treat cardiovascular or peripheral diseases.

Drug-eluting Balloon Catheters Market Report Attributes
Report Attribute	Details
Base Year:	2022
Drug-eluting Balloon Catheters Market Size in 2022:	USD 581.9 Million
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	11.5%
2032 Value Projection:	USD 1.7 Billion
Historical Data for:	2018 to 2022
No. of Pages:	170
Tables, Charts & Figures:	342
Segments covered:	Product, Material, End-use, and Region
Growth Drivers:	Growing prevalence of peripheral and cardiovascular diseases Technological advancements in drug-eluting balloon catheters Increasing preference for minimally invasive procedures Rising geriatric population globally Increasing diabetes incidence
Pitfalls & Challenges:	High cost of product Risk of infection associated with the use of drug-eluting balloon catheters

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for drug-eluting balloon catheters was valued at around USD 582 million in 2022 and will surpass USD 1.7 billion by 2032, driven by advancements in drug delivery technologies, preference for minimally invasive procedures, and increasing incidence of cardiovascular diseases.

The hospitals and clinics segment accounted for a majority share in 2022 and is projected to reach over USD 964 million in 2032 driven by favourable reimbursement policies for procedures involving drug-eluting balloon catheters.

North America market accounted for USD 254.9 million in 2022 and is anticipated to record healthy growth through 2032 driven by an aging population, and growing awareness among healthcare professionals and patients about advanced interventional options.

Aachen Resonance GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International, Biotronik AG are some of the major industry contenders.